<DOC>
	<DOCNO>NCT02155374</DOCNO>
	<brief_summary>Objective : determine regimen result best glycemic control safety profile , express glucose value within target range occurrence hypoglycemia . Secondary objective compare patient satisfaction , clinical outcome toxicity . Study design : Randomized open label cross-over study Study population : Patients ≥ 18 year , develop glucocorticoid induce hyperglycemia require initiation adjustment antihyperglycemic agent previous chemotherapy cycle . Patient ≥2 cycle chemotherapy schedule , 3-10 consecutive day ≥12,5mg prednisone-equivalent glucocorticoid wash-out period 4-38 day cycle . Intervention : subject treat insulin regimen A B random order two consecutive cycle chemotherapy . A ) intermediate act insulin 0.01 IU / mg prednisone-equivalent / kg body weight daily subcutaneous B ) Short-acting insulin accord slide scale regimen , dose adjust current grade hyperglycemia . Main study parameter : Difference fraction blood glucose measurement ( BGM ) within target range occurrence hypoglycemia . Nature extent burden risk associate participation , benefit group relatedness : Both study treatment slight variation regular care glucocorticoid induce hyperglycemia . Glycemic control likely improve due treatment increase counsel . All subject receive treatment regimen . The burden consist 16-32 extra BGMs 2 x 4-10 day , wear glucose sensor , 1 venipuncture ( HbA1c creatinin determine routine laboratory within 3 month start ) , 1 randomization visit outpatient clinic . Potential risk occurrence hypoglycemia , present insulin therapy . The investigator account risk give subject dietary advice education prevent , recognize treat hypoglycemia .</brief_summary>
	<brief_title>Glucose Control Glucocorticoid Induced Hyperglycemia During Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Short-Acting</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<criteria>Age ≥ 18 year Written inform consent Glucocorticoid induce hyperglycemia previous cycle chemotherapy require therapy initiation adjustment Duration glucocorticoid cycle 310 consecutive day 438 glucocorticoidfree day 2 cycle Prednisoneequivalent dose ≥ 12,5mg At least 2 cycle chemotherapy receive History hypounawareness Continuous tube parental feeding Continuous ( maintenance ) systemic glucocorticoid therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Glucocorticoid induce hyperglycemia , insulin , chemotherapy</keyword>
</DOC>